ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAC0. A total of 9 filers reported holding ACORDA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,539,998 | -36.6% | 2,000,000 | -33.3% | 0.01% | -28.6% |
| Q4 2021 | $2,430,000 | 0.0% | 3,000,000 | 0.0% | 0.01% | -22.2% |
| Q3 2021 | $2,430,000 | +9.6% | 3,000,000 | 0.0% | 0.02% | +28.6% |
| Q2 2021 | $2,217,143 | +2.8% | 3,000,000 | 0.0% | 0.01% | -26.3% |
| Q1 2021 | $2,157,143 | – | 3,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CANYON CAPITAL ADVISORS LLC | 25,875,000 | $15,266,250 | 1.51% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 45,283,000 | $30,905,648 | 1.28% |
| Saltoro Capital, LP | 1,500,000 | $877,500 | 0.79% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 30,000,000 | $19,200,000 | 0.48% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 52,324,000 | $28,244,146 | 0.45% |
| Soros Fund Management | 27,951,000 | $15,512,805 | 0.22% |
| D. E. Shaw & Co., Inc. | 14,000,000 | $7,980,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 5,018,000 | $3,424,785 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |